Injectable platelet-rich fibrin with a minimally invasive non-surgical technique for treating intrabony periodontal defects
Official title: Injectable Platelet-Rich Fibrin (i-PRF) With Minimally Invasive Non-Surgical Technique in Treatment of Periodontal Intrabony Defects: A Randomized Clinical Trial
Run by October 6 University · NCT07613606 · Data updated 2026-11-12
This study tests whether adding injectable platelet-rich fibrin to a minimally invasive non-surgical treatment helps regenerate bone in intrabony periodontal defects.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | October 6 University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | March 1, 2026 |
| Main results expected | December 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | May 29, 2026 |
| Trial ID | NCT07613606 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with periodontitis stage III (grades B or C) having single-rooted or multi-rooted teeth with bilateral two- or three-walled intrabony defects and no systemic conditions affecting periodontal healing.
✕Probably not a fit
Patients with systemic diseases, tobacco use, recent periodontal surgery, or other exclusion criteria may not experience additional benefit from the adjunctive i-PRF approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates the adjunctive use of injectable platelet-rich fibrin (i-PRF) with a minimally invasive non-surgical technique (MINST) for regenerative treatment of intrabony periodontal defects. Participants are adults with periodontitis stage III (grades B or C), with bilateral comparable intrabony defects. The approach combines MINST to debride the defect with i-PRF to potentially enhance tissue regeneration, monitored clinically and radiographically. The study emphasizes soft tissue preservation and primary wound closure as key factors for optimal regeneration. Outcomes will inform whether i-PRF adds benefit over MINST alone in promoting periodontal regeneration.
Why it matters
Potential benefit: If successful, patients may experience better regeneration of bone and supporting tissues around affected teeth with a less invasive procedure.
How similar studies have gone: Previous approaches using biologics like platelet-rich products have shown regenerative potential in periodontal defects, but results vary and this combination with MINST is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients of both genders \>18 years old, medically free of systemic diseases affecting periodontal regeneration. * Diagnosis of 'periodontitis' stage III (grades B or C). * Single-rooted and multi-rooted vital teeth in either the maxilla or the mandible. * Presence of comparable bilateral two- or three-walled intrabony defects \[probing pocket depth (PPD), \> 5 mm with intrabony defect depth ≥ 3 mm, from the alveolar crest to the defect base, at screening radiograph\] not in a furcation-involved tooth. Exclusion Criteria: * Patients with systemic illness known to affect the outcome of periodontal therapy, including diabetes, immune deficiencies, etc. * Pregnant and lactating women * Current use of any form of tobacco. * Non-surgical periodontal treatment in the past 6 months, or surgical periodontal treatment in the past 12 months. * Degree 2 or 3 mobility of the involved sites.6. * Presence of periapical pathology, acute infection, or subgingival restoration which could interfere with clinical measurements.
Where it's running
-
October 6 University
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Amir R Elngar, B.D.S
- Email: amirreda059@gmail.com
- Phone: 00201004634587
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
i-PRF bioactive matrix with coronally advanced flap vs connective tissue graft for gingival recessions
This trial tests whether a bioactive matrix made with i-PRF and L-PRF, used with a coronally advanced flap, can provide similar or better root coverage than a traditional connective tissue graft in adults with Miller Class I or II gingival recessions.
-
MINST with or without e-PRF for intrabony periodontal defects
This trial tests whether adding Extended Platelet-Rich Fibrin (e-PRF) to a minimally invasive non-surgical technique (MINST) improves bone and gum healing in adults with periodontal intrabony defects.
-
Treatment of peri-implantitis using platelet-rich fibrin
This study is testing whether adding platelet-rich fibrin to surgery can help people with peri-implantitis heal better and improve bone growth around their dental implants.
-
Injectable Platelet-Rich Fibrin Added to MINST for Grade II Furcation Defects
Aiming to see if adding injectable platelet-rich fibrin to a minimally invasive non-surgical cleaning helps treat certain tooth defects better than MINST alone.
-
Injectable platelet-rich fibrin for faster orthodontic tooth movement
This study is testing if an injectable treatment made from platelets can help speed up tooth movement for people getting braces.
-
Alveolar Bone Regeneration with Advanced Platelet-Rrich Fibrin and Strontium-Doped Hydroxyapatite
This study tests whether using advanced platelet-rich fibrin (A-PRF) alone or with strontium-doped hydroxyapatite (Sr-HA) helps regenerate bone after tooth extraction better than letting the socket heal on its own.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.